Open AccessPI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron
Author(s) -
Acharya Arpan,
Pathania Anup S.,
Pandey Kabita,
Thurman Michellie,
Vann Kendra R.,
Kutateladze Tatiana G.,
Challagundala Kishore B.,
Durden Donald L.,
Byrareddy Siddappa N.
Publication year - 2022
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.806
Subject(s) - pi3k/akt/mtor pathway , replication (statistics) , medicine , discovery and development of mtor inhibitors , virology , covid-19 , computational biology , biology , genetics , apoptosis , disease , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom